Condition: Coronary Arterial Disease (CAD) · Coronary Arteriosclerosis · Sponsor: Ruijin Hospital
This is a combined cohort study with retrospectively and prospectively enrolled coronary artery disease (CAD) patients. All the patients will undergo clinical follow-up for up to 5 years, and repeat coronary CTA will be conducted after 2 years. Comprehensive morphological and functional plaque analysis will be performed. The impact of these morphological and functional parameters, alongside cardiometabolic factors and pharmacological treatments on plaque progression and the occurrence of major adverse cardiovascular events (MACEs) will be analyzed. In addition, intracoronary imaging techniques will be used to improve the accuracy of plaque analysis by coronary CTA.
This description comes directly from the study's public registry record.
Xiaoqun Wang · +86 21 64370045 671605 · wangxq@shsmu.edu.cn
Shuo Feng · +86 21 64370045 671603 · fengshuorv@hotmail.com
Always discuss trial participation with your own doctor first.
| CAAC East China Aviation Personnel Medical Appraisal Center, Civil Aviation Shanghai Hospital | Shanghai, China | Recruiting |
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06794684